Online citations, reference lists, and bibliographies.
← Back to Search

Expression Of Mdr1 And Mdr3 Multidrug-resistance Genes In Human Acute And Chronic Leukemias And Association With Stimulation Of Drug Accumulation By Cyclosporine.

H. Herweijer, P. Sonneveld, F. Baas, K. Nooter
Published 1990 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
We determined the expression levels of the mdr1 and mdr3 multidrug-resistance genes (also known as PGY1 and PGY3, respectively) in peripheral blood cells from 69 adult patients with acute and chronic leukemias, using an RNase protection assay. Expression of mdr1 was found in samples from patients with acute nonlymphocytic leukemia (13 of 17), chronic myelocytic leukemia (CML, chronic phase, 10 of 10; blast crisis, three of four), acute lymphocytic leukemia (ALL, eight of 11), B-cell chronic lymphocytic leukemia (B-CLL, 17 of 17), hairy cell leukemia (HCL, one of two), and T-cell prolymphocytic leukemia (one of one), but not in B-cell prolymphocytic leukemia (B-PLL, 0 of seven). Expression of mdr3 was only detected in samples from B-cell lymphocytic leukemias: CML, lymphoid blast crisis (one of one), B-cell ALL (two of two), B-CLL (17 of 17), B-PLL (seven of seven), and HCL (two of two). In vitro drug uptake studies by on-line flow cytometry showed that in leukemia cells expressing either mdr1 or mdr3, the steady-state accumulation of daunorubicin could be significantly increased by addition of cyclosporine and, to a lesser extent, by verapamil. Because cyclosporine and verapamil are known as inhibitors of the mdr1-encoded P-glycoprotein drug-efflux pump, and because the mdr1 and mdr3 genes are highly homologous, our data suggest that the mdr3 gene encodes a functional drug pump in B-cell lymphocytic leukemias. The results of this study may have implications for clinical therapy for acute or chronic leukemias expressing the mdr1 or mdr3 gene, in particular, treatment with combinations of cytotoxic drugs plus agents that reverse multidrug resistance. Since mdr1 and mdr3 are frequently expressed in untreated as well as treated leukemia, such combination therapy should be considered for untreated patients as well as treated patients.



This paper is referenced by
10.1016/j.biopha.2018.06.015
The effects of DMARDs on the expression and function of P-gp, MRPs, BCRP in the treatment of autoimmune diseases.
Yi-jin Wu (2018)
10.18632/oncotarget.14491
Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients
L. Hontecillas-Prieto (2017)
Thiosemicarbazones Target Multiple Resistance Pathways in Cancer
A. Stacy (2016)
New insights into the mechanisms of multidrug resistance in cancers.
N. Montazami (2015)
Recombinant AAV-mediated Gene Therapy Approaches to Treat Progressive Familial Intrahepatic Cholestasis Type 3
Susan M. Siew (2014)
10.1016/j.biopha.2013.09.004
Expression of MDR1 and MDR3 gene products in paclitaxel-, doxorubicin- and vincristine-resistant cell lines.
R. Januchowski (2014)
Identification et mécanisme d'action de modulateurs sélectifs du transporteur ABCG2 responsable de la chimiorésistance de cellules cancéreuses
C. Gauthier (2014)
Monoclonal Antibodies MRP2, MRP3, MRP5, and MDR3 P-Glycoprotein with a Panel of Specific Detection of Multidrug Resistance Proteins MRP1,
G. Scheffer (2013)
10.1007/978-3-7091-0442-2_7
Inhibition of ATP-Binding Cassette Transporters by Chinese Herbs and Phytochemicals
T. Efferth (2013)
10.1042/BSR20130067
Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR–CML cell lines?
V. Rumjanek (2013)
meeting held in San Diego, CA, December 1997. 833 (Valspodar) : Presented in part at the American Society of Hematology Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With
P. Greenberg (2013)
Apport des modèles PBPK dans l'optimisation thérapeutique des inhibiteurs des calcineurines en transplantation
C. Gérard (2012)
TKI resistance in CML cell lines : investigating resistance pathways.
Carine Tang (2012)
10.3892/ijo.2012.1433
Expression of multidrug resistance-associated proteins in paediatric soft tissue sarcomas before and after chemotherapy.
A. Citti (2012)
10.2174/138920111795164048
Revisiting the ABCs of multidrug resistance in cancer chemotherapy.
A. Tiwari (2011)
in CD34+ acute myeloid leukemia cells Predominance of functional multidrug resistance (MDR-1) phenotype
P. Sonneveld (2011)
Drug resistance in chronic lymphocytic leukaemia
Ilkka Kivekäs (2011)
10.1080/15257770.2011.597372
Translocation of Nucleoside Analogs Across the Plasma Membrane in Hematologic Malignancies
P. Fernández-Calotti (2011)
10.4081/hr.2011.e3
Correlation between the type of bcr-abl transcripts and blood cell counts in chronic myeloid leukemia – a possible influence of mdr1 gene expression
G. Balatzenko (2011)
10.2165/11317350-000000000-00000
Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I
C. Staatz (2010)
10.2165/11317550-000000000-00000
Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II
C. Staatz (2010)
10.1007/s00432-009-0670-9
Expression of multidrug resistance-associated ABC transporters in B-CLL is independent of ZAP70 status
A. Hoellein (2009)
10.1038/leu.2009.176
Antileukemic activity of valproic acid in chronic lymphocytic leukemia B cells defined by microarray analysis
B. Stamatopoulos (2009)
10.1002/9783527627424.CH11
Bile Canalicular Transporters
D. D. Waart (2009)
10.1111/j.1365-2141.2008.07197.x
Emerging stem cell concepts for imatinib‐resistant chronic myeloid leukaemia: implications for the biology, management, and therapy of the disease
P. Valent (2008)
10.1097/FTD.0b013e31816babef
Role of Pharmacogenetics of Immunosuppressive Drugs in Organ Transplantation
E. Thervet (2008)
10.1080/15376510701795306
Importance of Drug Transporters in Pharmacokinetics and Drug Safety
P. Ward (2008)
Regulation of biliary lipid secretion Frijters
G. C.M. (2007)
10.1111/J.1744-7909.2007.00440.X
Effects of P‐Glycoprotein Inhibitor and Elicitor on the Salt Tolerance of Rice Seedlings
Liang-Jun Fang (2007)
10.1016/J.BBCAN.2007.05.002
Chemotherapy-induced resistance by ATP-binding cassette transporter genes.
J. Gillet (2007)
Imatinib-resistant chronic myeloid leukemia (CML): Current concepts on pathogenesis and new emerging pharmacologic approaches
P. Valent (2007)
10.1007/BF02634176
Cellular models for multiple drug resistance in cancer
M. Clynes (2007)
See more
Semantic Scholar Logo Some data provided by SemanticScholar